Donghua Technology: Inner Mongolia New Materials, a holding subsidiary, signed a product sales contract with Yulin Chemical of Shaanxi Coal Group. Donghua Technology announced that China National Chemical New Materials Co., Ltd., a holding subsidiary, plans to sign a Product Sales Contract with Yulin Chemical Co., Ltd. of Shaanxi Coal Group, stipulating that Yulin Chemical will sell ethylene glycol and by-products produced by Inner Mongolia New Materials. The contract is from October 20, 2024 to December 31, 2025. Product prices are divided into temporary pricing and settlement price, and are priced according to the principle of marketization. From the beginning of 2024 to the disclosure date, the Company had related transactions with Yulin Chemical and its concerted parties, mainly to provide engineering services to Yulin Chemical and its concerted parties, with the related transactions amounting to 438 million yuan. Institution: The sinking trend of the domestic market is remarkable. The Report on Career Development of Domestic Servants released in 58 shows that in 2024, the demand for nursing old nannies will increase by 21% year-on-year, the demand for raising children will increase by 23%, and the demand for high-end domestic services such as elite housekeepers and children's growth companions will increase by 34%. In addition, the sinking trend of domestic training is obvious, and the number of participants in second-tier and below cities has increased by 229% year-on-year.
Kangxinuo Bio: Dong Xiaoman was appointed as the new general partner of Shanghai Qianxizhi, and Kangxinuo Bio (06185) issued an announcement. On December 13, 2024, Dr. Zhu informed the board of directors that in view of the need for sufficient time to manage the employee stock ownership platform, all the partners of the employee stock ownership platform unanimously decided to appoint Well Lee as the new general partner of Shanghai Qianxiyi and Shanghai Qianxirui respectively, and Dong Xiaoman as the new general partner of Shanghai Qianxizhi. Therefore, Dr. Zhu is no longer the general partner of the employee stock ownership platform and no longer has the right to exercise the voting rights of the shares held by the employee stock ownership platform.Daye shares: the proposed acquisition of 100% equity of Al-Kogerte GmbH constitutes a major asset restructuring. Daye shares announced that the company intends to acquire 100% equity of Al-Kogerte GmbH in cash through its wholly-owned subsidiary RUNBO INT PTE.LTD, which constitutes a major asset restructuring of the company.BMO raised the target price of Chevron from $170 to $175.
Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.Market news: Sam Altman, founder of OpenAI, will donate $1 million to the inauguration fund of President-elect Trump. According to reports, Altman plans to donate to the Presidential Inaugural Committee in his own name, instead of directly donating by OpenAI.Senior EU officials: The foreign ministers of 27 EU countries will approve the 15th round of sanctions against Russia and new sanctions "against hybrid operations" on December 16th.
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide
12-14